New partnership: joimax® joins forces with JAPAN MEDICALNEXT CO., LTD.

Karlsruhe (GER), 16 June 2020
 joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is starting as of now a new partnership in Japan. The distributor JMC- JAPAN MEDICALNEXT CO., LTD. and joimax® are pursuing a long-term sales cooperation that will result in an extensive distribution agreement for the entire Japanese market.

joimax® joins forces with JAPAN MEDICALNEXT CO., LTD.

joimax® is looking forward to working with a partner strong as JMC, says joimax® Founder and CEO Wolfgang Ries and adds, “a company that has the necessary personnel, expertise, as well as the corresponding specialization and penetration of the market”. Masayuki Yoshimura, President and CEO of JMC, explains, “We are very excited to partner with joimax®. With our shared vision for advancing the field of minimum invasive spinal surgery, we are looking forward to introducing the globally recognized joimax® products in Japan”. Thus, joimax® strengthens its sales activities in Japan and enters into another important partnership in Asia.

JAPAN MEDICALNEXT CO., LTD. founded in 1992 is located in Osaka, Japan. With 314 employees at its locations and an Orthopedics Division that will focus on joimax® products, the company is a wholly-owned entity of MC Healthcare, Inc. (subsidiary of Mitsubishi Corporation) and prominent supplier of medical devices in Japan.

FDA Approves joimax® Intracs®em Electromagnetic Navigation System for Endoscopic Minimally Invasive Spine Surgery

IRVINE, CA – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce that Intracs® em, its electromagnetic navigation tracking and control system, has been approved by the FDA.

The Intracs® em Navigation System allows for spinal procedures to be carried out with minimal X-ray control, drastically reducing radiation exposure, access time, and the entire length of the surgical procedure. In fact, all joimax® instruments and scopes can be tracked and accurately navigated through the appropriate sensors, which improves safety, expands endoscopic indications, and flattens the learning curve.

Intracs®em is a multiyear development. Its first cadaveric trials were made with a group of surgeons at the ESPINEA® Labs in Karlsruhe, Germany and Irvine, CA.

FDA Approval , joimax endoscopic navigation system Intracs em

According to Prof. Dr. med. Michael Kraus of ORTHIX Zentrum in Augsburg, Germany, who headed the preliminary trials: “Using Intracs® em Navigation System in the full endoscopic spine surgery is safe and easily applicable. The technology helps master precise access to the spine, and the clinical trials have confirmed the technique’s multiple advantages.”

Prof. Dr. Chris Hofstetter of UW Medical Center in Seattle, Washington, USA, adds: “joimax® Intracs®em constitutes a highly precise image-guided navigation platform designed for the specific needs of full-endoscopic spine surgery. Using electromagnetic navigation technology allows to track the leading edge of endoscopic instruments in real time, and facilitates needle targeting and orientation during the surgery, while minimizing radiation exposure. No doubt, this technology will expand the indications for full-endoscopic spine surgery and pave the way for innovations in minimally invasive arthrodesis techniques.”

joimax® is also excited to announce its second joint Global Symposium being held in partnership with Integrity Implants, Inc., August 21 – 22. For details, visit www.joimax.com.